{"doi":"10.1016/j.brs.2020.06.019","title":"A case of non-affective psychosis followed by extended response to non-stimulation in deep brain stimulation for obsessive-compulsive disorder","abstract":"We present a case of acute onset of psychotic symptoms, without signs of hypomania, following DBS for intractable OCD in a patient with no prior history of psychosis or delusional beliefs. The patient was a male in his early 20s with a history of intractable OCD, receiving DBS of the ventral capsule/ventral striatum (VC/VS) implanted as part of a randomized clinical trial of DBS for OCD (NCT00640133). The study sought to investigate effectiveness of DBS as a treatment for intractable OCD, as preliminary data had shown promising therapeutic effects [1Greenberg B.D. Price L.H. Rauch S.L. Friehs G. Noren G. Malone D. Carpenter L.L. Rezai A.R. Rasmussen S.A. Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues.Neurosurg Clin North Am. 2003; 14: 199-212Abstract Full Text Full Text PDF PubMed Scopus (197) Google Scholar, 2Abelson J.L. Curtis G.C. Sagher O. Albucher R.C. Harrigan M. Taylor S.F. et al.Deep brain stimulation for refractory obsessive-compulsive disorder.Biol Psychiatr. 2005; 57: 510-516Abstract Full Text Full Text PDF PubMed Scopus (380) Google Scholar]. The patient’s OCD symptoms began at age 11, marked by exactness, thoroughness and perfectionism. His obsessions were accompanied by near constant doubt and a “need to know”, as well as, concerns about offending others, leading to excessive reassurance seeking. Prior to seeking DBS for OCD, he had received numerous conventional treatments without substantial symptom improvement, including trials of at least three serotonin reuptake inhibitors (SRI), one of which was clomipramine; all trials exceeded 6 months in length and were augmented with benzodiazepines (e.g., clonazepam). Dopamine antagonist augmentation was also tried. Cognitive behavior therapy, including exposure and response prevention, was tried over a period of many years, both in traditional weekly outpatient sessions as well as in a specialty residential treatment setting. At the time of his initial assessment for DBS, his OCD severity rated in the extreme range on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS; baseline score = 33). He had a history of depression but was not in a depressive episode at the time of initial evaluation for DBS. The surgery to implant the DBS device was unremarkable, and placement was verified by imaging (Fig. 1). Active stimulation was delivered to contact 2 (left) and contact 3 (right), both monopolar; contact points were chosen following post operative titration for most acute affective effect and stimulus optimization. At the patient’s nine-month follow-up, his OCD symptoms had improved approximately 33% (Y-BOCS = 22), representing a partial response. Approximately 18 months after implantation, the patient presented with an acute onset of psychotic symptoms shortly after DBS amplitude was increased. At the following visit DBS voltage was reduced, but psychotic symptoms persisted. The patient described ideas of reference, magical thinking unrelated to any previous OCD symptoms (e.g., talking to trees), and other delusional beliefs. He felt that something was not right and engaged in delusional behaviors in attempts to “fix” himself (e.g., hugging trees to get them to take the evil out of him). There was no accompanying grandiosity, euphoria, pleasure-seeking, or change in sleep suggesting hypomania. His functioning worsened in tandem. An antipsychotic was started (risperidone 2mg/day). The patient had no prior history of psychotic symptoms, psychotropic medications had been stable, and no recent substance use. Family history was not available. Psychotic symptoms improved somewhat two weeks after risperidone was started, as did daily functioning. However, ideas of reference persisted. Risperidone was increased to 4mg daily, without further benefit. After discussion with the patient, risperidone dosage was again increased and DBS was stopped on a trial basis. When the patient was re-evaluated two weeks later, delusions were no longer pre","journal":"Brain stimulation","year":2020,"id":115048,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9526,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":540606,"name":"Sarah L. Garnaat","orcid":null,"position":1,"is_corresponding":false},{"id":540607,"name":"Andrew K. Corse","orcid":null,"position":2,"is_corresponding":false},{"id":539670,"name":"Nicole McLaughlin","orcid":"0000-0002-4016-2747","position":3,"is_corresponding":false},{"id":353178,"name":"Benjamin D. Greenberg","orcid":"0000-0002-5648-0002","position":4,"is_corresponding":false},{"id":287652,"name":"Thilo Deckersbach","orcid":"0000-0001-7643-0347","position":5,"is_corresponding":false},{"id":333806,"name":"Emad N. Eskandar","orcid":"0000-0003-4743-2938","position":6,"is_corresponding":false},{"id":336140,"name":"Darin D. Dougherty","orcid":"0000-0003-4691-4353","position":7,"is_corresponding":false},{"id":274326,"name":"Alik S. Widge","orcid":"0000-0001-8510-341X","position":8,"is_corresponding":false},{"id":540605,"name":"Abigail A. Testo","orcid":null,"position":0,"is_corresponding":true}],"reference_count":11,"raw_metadata":null,"created_at":"2026-07-18T23:13:33.226937Z","pmid":"32622060","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}